Key points are not available for this paper at this time.
The increasing prevalence of antibiotic-resistant bacterial infections, coupled with the decline in the number of new antibiotic drug approvals, has created a therapeutic gap that portends an emergent public health crisis.
Ergene et al. (Mon,) studied this question.